Combined Nivolumab and Ipilimumab in Melanoma Metastatic to the Brain
Por um escritor misterioso
Descrição
Cureus, Aggressive Stereotactic Radiosurgery Coupled With Immune and Targeted Therapy for Recurrent Melanoma Brain Metastases: A Case Report and Literature Review
Frontiers Factors Determining Long-Term Antitumor Responses to Immune Checkpoint Blockade Therapy in Melanoma
Stereotactic radiosurgery combined with nivolumab or Ipilimumab for patients with melanoma brain metastases: evaluation of brain control and toxicity, Journal for ImmunoTherapy of Cancer
Frontiers Successful Treatment of Unresectable Advanced Melanoma by Administration of Nivolumab With Ipilimumab Before Primary Tumor Resection
Nivolumab + Ipilimumab Shows Efficacy for Untreated Brain Mets
Full article: Efficacy and safety of the combined use of ipilimumab and nivolumab for melanoma patients with brain metastases: a systematic review and meta-analysis
Stereotactic radiosurgery combined with nivolumab or Ipilimumab for patients with melanoma brain metastases: evaluation of brain control and toxicity
Combined Nivolumab and Ipilimumab in Melanoma Metastatic to the Brain
Imaging of Response to Radiosurgery and Immunotherapy in Brain Metastases: Quo Vadis?
Melanoma brain metastases, immunotherapy as standard of care
de
por adulto (o preço varia de acordo com o tamanho do grupo)
